At The Behest Of Big Pharma, US Threatens Colombia Over Compulsory Licensing Of Swiss Drug
from the destroying-lives,-destroying-peace dept
As Techdirt readers well know, Big Pharma really hates compulsory licensing of its patented drugs, where a country steps in and allows an expensive drug to be made more cheaply in order to provide wider access for its people. Such massive pressure is applied to nations contemplating this move, that even global giants like India quail. A new story is unfolding that reveals just how far companies are prepared to go in order to prevent it from happening. It concerns Colombia's possible use of a compulsory license for the drug imatinib, sold under the name Glivec, and used to treat leukemia. Despite the fact that the company holding patents on the drug, Novartis, is Swiss, the US has started to lean heavily on Colombia in order to persuade it not to go ahead with the move.
KEI has obtained a copy of a letter from Andrés Floréz at the Embassy of Colombia in Washington, DC, to the Minister of Health in Colombia, reporting on a meeting between embassy officials and Everett Eissenstat. He's the Chief International Trade Counsel for the US Senate Committee on Finance, under Senator Orrin Hatch. Apparently, Eissenstat conveyed quite forcefully his views on the negative consequences for Colombia if it decided to issue a compulsory license on the cancer drug Glivec:
Eissenstat mentioned that although Novartis is not an American company, the US pharmaceutical industry was very worried about the possibility that the case would become a precedent that could be applied to any patent in any industry which, according to him, could lead to the reputation of our country's respect for intellectual property rights being viewed as impaired and Colombia becoming one among those countries that would have special treatment...
Nice little country you have there -- be a shame if something happened to it. Stat News mentioned a couple of forms that "special treatment" might take:
Einssenstat also mentioned that, if the Ministry of Health does not correct this situation, the US pharmaceutical industry and related interest groups could become very vocal and interfere with other interests that Colombia could have in the US.A free-trade treaty between the two countries went into effect four years ago, which obligates Colombia to comply with various international trade laws. Florez also cautioned that issuing a compulsory license for the Novartis drug may "weaken support" for bringing Colombia into the Trans-Pacific Partnership, a trade pact between 12 countries in the Asia and Pacific regions that must still be approved by Congress.
But the most extraordinary threat is the following, reported here by KEI:
Senator Hatch was so opposed to the idea of a compulsory license on the patent for a $40+ Billion cancer drug made by a Swiss company that he was willing to find an extremely sensitive area for the Colombian people and use it as leverage. The [Paz Colombia] peace process in question is the hopeful conclusion to decades of fighting in the country with guerrilla rebels that has led to hundreds of thousands of deaths.
The US is willing to jeopardize the entire "Paz Colombia" peace plan, all because Big Pharma is outraged a developing country might dare to use its international right to issue a compulsory license. As KEI Director James Love commented:
The use of these back channel methods of conveying threats and pressure is common, and the leak of these two letters provides insight into why governments that have the right to issue compulsory licenses rarely do. The fact that after meeting with Eissenstat, the Colombian Embassy connects the patent dispute to the funding of the Colombian peace process illustrates how the United States can link health and national security together in ways that a harmful to both.
It can surely only be a matter of time before Colombia obediently toes the line, and recognizes that Big Pharma's patents and profits are much more important than the health and lives of its people.
Follow me @glynmoody on Twitter or identi.ca, and +glynmoody on Google+
Thank you for reading this Techdirt post. With so many things competing for everyone’s attention these days, we really appreciate you giving us your time. We work hard every day to put quality content out there for our community.
Techdirt is one of the few remaining truly independent media outlets. We do not have a giant corporation behind us, and we rely heavily on our community to support us, in an age when advertisers are increasingly uninterested in sponsoring small, independent sites — especially a site like ours that is unwilling to pull punches in its reporting and analysis.
While other websites have resorted to paywalls, registration requirements, and increasingly annoying/intrusive advertising, we have always kept Techdirt open and available to anyone. But in order to continue doing so, we need your support. We offer a variety of ways for our readers to support us, from direct donations to special subscriptions and cool merchandise — and every little bit helps. Thank you.
–The Techdirt Team
Filed Under: colombia, compulsory licensing, everett eissenstat, glivec, health, orrin hatch, threats, trade agreements
Companies: novartis
Reader Comments
Subscribe: RSS
View by: Time | Thread
Leaker
[ link to this | view in chronology ]
Big Pharma only cares about it's shareholders, not about actual patients.
[ link to this | view in chronology ]
Looks like Columbia is in a lose-lose proposition
[ link to this | view in chronology ]
Re: Looks like Columbia is in a lose-lose proposition
[ link to this | view in chronology ]
Re: Re: Looks like Columbia is in a lose-lose proposition
[ link to this | view in chronology ]
Re: Re: Re: Looks like Columbia is in a lose-lose proposition
[ link to this | view in chronology ]
Re: Re: Re: Looks like Columbia is in a lose-lose proposition
Well, not you personally. Your government and corporations (are those even separate?).
[ link to this | view in chronology ]
Re: Re: Re: Looks like Columbia is in a lose-lose proposition
[ link to this | view in chronology ]
Live by IP...
Abolish IP.
[ link to this | view in chronology ]
[ link to this | view in chronology ]
US Threatens Colombia Over Compulsory Licensing Of Swiss Drug
[ link to this | view in chronology ]
Here is a way to make everyone happy
There is a simple solution that would make everyone happy. Big Pharma should be very happy because compulsory licensing would cease to exist.
Simply eliminate patents on drugs.
Problem solved. Everyone happy.
[ link to this | view in chronology ]
Re: Here is a way to make everyone happy
[ link to this | view in chronology ]
Sleep at night.
[ link to this | view in chronology ]
[ link to this | view in chronology ]
[ link to this | view in chronology ]
Re:
[ link to this | view in chronology ]
Re: Re:
[ link to this | view in chronology ]
[ link to this | view in chronology ]
Re:
[ link to this | view in chronology ]
Re: Re:
China..................apx. $145 Billion
Saudi Arabia.......apx. $82 Billion
need I go on?
[ link to this | view in chronology ]
Re: Re: Re:
[ link to this | view in chronology ]
Go against US interests and get your country bombed into oblivion in the name of "democracy and freedom"
[ link to this | view in chronology ]
We will also need to show the falsehood of the industry's claim that its ill-gotten profits are helping patients by supporting drug research. Not only is the ratio of profits to research very small, but little of that research actually ends up helping patients. The patent profits fuel just enough research to make another patentable drug, which is used to continue the cycle of ghoulish extortion.
[ link to this | view in chronology ]
Re:
Needs many, many, more countries to follow suit because this bs is still going on globally.
[ link to this | view in chronology ]
Re:
[ link to this | view in chronology ]
That's not a threat, it's an incentive.
[ link to this | view in chronology ]
"Liang Hong, one of the GSK executives....was quoted by China’s state-run media as saying that the costs of the bribes were eventually wrapped up into the price of medicines, accounting for up to 30% of a drug’s final price"...
....is true in China, how much more so in every other country in the world?
The majority of drug companies really need to be turned upside down, torn apart, and exposed for the crimes they commit against humanity.
You only have to talk to the relatives of those who've died as a direct result of not being able to afford vital medicines (or died of exposure to biological weapons - and who creates those?), to reach that conclusion.
Let's not kid ourselves.
http://knowledge.wharton.upenn.edu/article/chinas-bitter-medicine-foreign-drug-companies/
[ link to this | view in chronology ]
Re:
[ link to this | view in chronology ]